Research Article

The Degree of Plasma Oxidized Low-Density Lipoprotein Level Decrease Is Related to Clinical Outcomes for Patients with Acute Ischemic Stroke

Table 3

Logistic regression model for predictors of clinical outcomes.

Neurological improvement at dischargeFavorable functional prognosis at 90 days
Unadjusted OR (95% CI) valueAdjusted OR (95% CI) valueUnadjusted OR (95% CI) valueAdjusted OR (95% CI) value

Age, y0.98 (0.95, 1.00)0.060.96 (0.93, 0.99)0.020.99 (0.97, 1.02)0.66
Male, (%)0.53 (0.29, 0.96)0.040.52 (0.23, 1.78)0.120.87 (0.43, 1.77)0.70
Alcohol use, (%)0.71 (0.35, 1.44)0.340.79 (0.37, 1.68)0.53
Tobacco use, (%)1.53 (0.85, 2.75)0.161.52 (0.51, 2.60)0.731.18 (0.61, 2.27)0.62
History of disease, (%)
Diabetes mellitus1.26 (0.70, 2.25)0.441.17 (0.59, 2.33)0.65
Hypertension0.83 (0.43, 1.59)0.570.71 (0.31, 1.58)0.40
TC, mmol/L1.26 (0.95, 1.67)0.100.83 (0.42, 1.63)0.591.10 (0.80, 1.50)0.58
TG, mmol/L1.08 (0.83, 1.41)0.561.19 (0.83, 1.69)0.35
HDL-C, mmol/L1.12 (0.46, 2.71)0.800.63 (0.23, 1.68)0.35
LDL-C, mmol/L1.42 (1.03, 1.94)0.031.65 (0.77, 3.51)0.21.19 (0.83, 1.71)0.35
CRP, mg/L0.96 (0.86, 1.07)0.471.15 (1.00, 1.33)0.071.14 (0.95, 1.37)0.15
Homocysteine, μmol/L0.96 (0.93, 1.02)0.240.97 (0.94, 1.01)0.120.97 (0.93, 1.00)0.09
DWI volumes (cm3)0.98 (0.95, 1.00)0.080.98 (0.95, 1.01)0.190.95 (0.92, 0.97)<0.010.94 (0.91, 0.97)<0.01
Neurological impairment severity at admission0.060.45<0.01<0.01
Mild, 2.75 (1.18, 6.41)0.021.80 (0.67, 4.81)0.2413.40 (5.32, 33.75)<0.019.18 (3.27, 25.80)<0.01
Moderate, NIHSS scores 5-92.36 (0.99, 5.65)0.051.85 (0.68, 5.04)0.236.30 (2.70, 14.71)<0.016.43 (2.31, 17.85)<0.01
Severe, ReferenceReferenceReferenceReference
Quartiles of oxLDL decrease<0.01<0.01<0.01
Δtertile 1 (mild decrease)ReferenceReferenceReferenceReference<0.01
Δtertile 2 (moderate decrease)4.28 (1.88, 9.74)<0.013.64 (1.46, 9.08)<0.014.30 (1.93, 9.58)<0.012.63 (1.02, 6.83)0.046
Δtertile 3 (significant decrease)7.23 (3.18, 16.44)<0.017.92 (3.14, 19.98)<0.018.57 (3.27, 22.43)<0.017.46 (2.40, 23.23)<0.01